HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity.

AbstractBACKGROUND:
Parameters of eosinophil inflammation have been suggested as markers of disease activity in atopic dermatitis (AD), but the value of urinary eosinophil protein X (U-EPX) in children with AD, as well as the influence of allergic sensitization, is not known.
METHODS:
We measured U-EPX in 59 atopic and 29 nonatopic children with mild (n = 32), moderate (n = 34), and severe (n = 22) AD, as well as in 64 controls.
RESULTS:
U-EPX was increased in children with AD (110; 67-164 microg/mmol creatinine, median; quartiles) compared to controls (62; 41-95, P<0.001). Children with mild (97; 63-164, P < 0.01), moderate (108; 67-157, P < 0.01), and severe disease (152; 99-202, P < 0.001) had levels of U-EPX higher than controls. U-EPX was significantly higher in children with severe AD than in mild and moderate disease (P < 0.05 for both). Children with AD and a positive skin prick test (120; 81-176) had higher levels of U-EPX than children with a negative skin prick test (87; 56-155, P<0.05).
CONCLUSIONS:
U-EPX is significantly increased in children with AD and may reflect disease activity. U-EPX may also reflect differences in eosinophil activation between those sensitized and those not sensitized to common allergens.
AuthorsK Oymar, R Bjerknes
JournalAllergy (Allergy) Vol. 55 Issue 10 Pg. 964-8 (Oct 2000) ISSN: 0105-4538 [Print] Denmark
PMID11030379 (Publication Type: Journal Article)
Chemical References
  • Blood Proteins
  • Eosinophil-Derived Neurotoxin
  • Ribonucleases
Topics
  • Blood Proteins (urine)
  • Child
  • Child, Preschool
  • Dermatitis, Atopic (etiology, physiopathology, urine)
  • Eosinophil-Derived Neurotoxin
  • Female
  • Humans
  • Infant
  • Male
  • Ribonucleases (urine)
  • Severity of Illness Index
  • Skin Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: